Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Int Assoc Provid AIDS Care ; 13(2): 106-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-23735855

RESUMO

There is a paucity of research demonstrating how HIV-funded services in Africa have improved equity and access to non-HIV services for both HIV-infected and uninfected patients. In this short communication, we describe the impact of an airborne outreach program to provide HIV services to high-HIV burden health facilities in rural Botswana. The analysis demonstrates how this HIV-funded program enhanced access to essential subspecialist services at several rural health facilities across Botswana.


Assuntos
Fortalecimento Institucional/métodos , Atenção à Saúde/métodos , Infecções por HIV/terapia , Acessibilidade aos Serviços de Saúde , Serviços de Saúde Rural , Botsuana , Fortalecimento Institucional/organização & administração , Mão de Obra em Saúde , Humanos , Avaliação de Programas e Projetos de Saúde , Estudos Retrospectivos
2.
J Int Assoc Provid AIDS Care ; 12(2): 90-4, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23315674

RESUMO

BACKGROUND: Data on the use of ritonavir-boosted darunavir (DRV/r) and/or raltegravir (RAL) in resource-limited settings are rare and there is currently no published data regarding their use among African children. Botswana has recently made DRV/r and RAL available for patients failing second-line antiretroviral therapy (ART). METHODS: Retrospective chart review of 4 multidrug-resistant pediatric patients on DRV/r- and/or RAL-based regimens. Viral load, CD4 count, adherence by pill count, and World Health Organization (WHO) clinical stage prior to and after switch to DRV/r- and/or RAL-based regimen were assessed. Antiretroviral therapy history, duration of virologic failure, and time to viral suppression were also noted. Genotypic resistance assays reviewed for mutations present prior to switch. RESULTS: All patients achieved viral suppression, showed improved/stable CD4 counts, and obtained or maintained WHO clinical treatment stage I, even after long-standing virologic/immunologic failure. CONCLUSIONS: Well tolerated by and effective in our patients, DRV/r and RAL provide potentially lifesaving ART options for children and adolescents in resource-limited settings failing ART due to ritonavir-boosted lopinavir (LPV/r) resistance.


Assuntos
Farmacorresistência Viral Múltipla , Infecções por HIV/tratamento farmacológico , Inibidores da Protease de HIV/uso terapêutico , Pirrolidinonas/uso terapêutico , Ritonavir/uso terapêutico , Sulfonamidas/uso terapêutico , Adolescente , Terapia Antirretroviral de Alta Atividade , Botsuana , Criança , Darunavir , Feminino , Humanos , Masculino , Raltegravir Potássico , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
3.
J Public Health Afr ; 4(2): e11, 2013 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-28299100

RESUMO

There is a paucity of research demonstrating how best to address inequalities in health and access to specialist care faced by rural disadvantaged populations in high HIV-prevalent settings in Sub Saharan Africa. Delivering equitable and cost-effective specialist clinical services in many parts of Africa is challenging, given human resource shortages, poor transport infrastructure and competing health priorities. In this report we describe how an airborne outreach program to provide HIV services to high HIV burden health facilities in rural Botswana has been an important catalyst for improving specialist service delivery across the spectrum of clinical care. The success of Botswana's airborne program is a consequence of many country-specific determinants as well as external funding support. We argue that lessons learned from the experience in Botswana are normative for other African settings. Specialist medical airborne outreach to rural hospitals can improve access to and quality of care, when part of a multifaceted, multidisciplinary intervention. Furthermore, we demonstrate how an HIV funded program can be a vehicle for enhanced access to essential sub-specialist clinicians in rural Botswana.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA